EMA Authorised: Leflunomide Zentiva (previously Leflunomide Winthrop) (leflunomide) — Zentiva k.s.

View source ↗

Summary

The EMA has authorised Leflunomide Zentiva for use in rheumatoid arthritis and psoriatic arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• Leflunomide Zentiva (leflunomide)

Snippet

Status: Authorised. Therapeutic area: Arthritis, Rheumatoid;Arthritis, Psoriatic. MAH: Zentiva k.s.. Decision date: 28/01/2026